newsfilter
← Latest News
GlobeNewswire·

INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026

  • INVO Fertility, Inc. (NASDAQ: IVF) announced a 1-for-5 reverse stock split effective at 12:01 a.m. ET on March 27, 2026.
  • Trading on the Nasdaq Capital Market will commence on a post-split basis on March 27, 2026, under the same symbol "IVF".
  • The CUSIP number for the common stock will change to 44984F880 as a result of the split.
  • Every 5 shares of outstanding common stock will be exchanged for 1 share, with fractional shares for record holders rounded up to the next whole share.
  • Beneficial holders of fractional shares through brokers will receive a cash payment for the fractional interest.
  • Post-split, the company will have approximately 1,615,419 shares issued and outstanding.
  • The authorized common stock will be proportionately adjusted to 50,000,000 shares following the effective time.
  • INVO Fertility operates four US fertility clinics & distributes its INVOcell device, which enables intravaginal culture (IVC) procedures.
  • The IVC procedure is positioned as a more natural, affordable alternative to traditional IVF & intrauterine insemination (IUI).